BIOMAT Database Logo BIOMAT Database Logo

Silent mixed corticotroph and somatotroph macroadenomas presenting with pituitary apoplexy. 2001

T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Department of Neurosurgery, Showa University School of Medicine, Tokyo, Japan. takumi@med.showa-u.ac.jp

We discuss three unique cases of pituitary macroadenoma presenting with pituitary hemorrhage but without typical endocrine symptomatology. Immunohistochemical analysis indicated positive reactivity for adrenocorticotropic hormone (ACTH) and growth hormone (GH), and in situ hybridization indicated the expression of proopiomelanocortin (POMC) and GH mRNA. We designated these cases silent mixed corticotroph and somatotroph adenoma. Patient 1 was a 30-year-old man, patient 2 was a 29-year-old woman, and patient 3 was a 59-year-old woman. All patients presented with a headache of sudden onset and visual disturbance. The patients did not exhibit typical Cushing's or acromegalic features. Serum ACTH level was remarkably elevated in patient 1, and slightly elevated in patients 2 and 3. In all patients, serum GH levels were within normal range and magnetic resonance imaging revealed an intra- and suprasellar mass with pituitary hemorrhage. Transnasal pituitary surgery in the three patients disclosed a pituitary adenoma producing ACTH and GH. In patient 2, the residual adenoma reappeared along with an intratumoral hemorrhage, and was resected by secondary transnasal surgery. Silent mixed corticotroph and somatotroph adenomas are characterized by the following: no endocrine symptoms; presentation dominated by mass effect symptoms; macroadenoma presenting with acute pituitary hemorrhage; and production of both ACTH and GH.

UI MeSH Term Description Entries
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010899 Pituitary Apoplexy The sudden loss of blood supply to the PITUITARY GLAND, leading to tissue NECROSIS and loss of function (PANHYPOPITUITARISM). The most common cause is hemorrhage or INFARCTION of a PITUITARY ADENOMA. It can also result from acute hemorrhage into SELLA TURCICA due to HEAD TRAUMA; INTRACRANIAL HYPERTENSION; or other acute effects of central nervous system hemorrhage. Clinical signs include severe HEADACHE; HYPOTENSION; bilateral visual disturbances; UNCONSCIOUSNESS; and COMA. Apoplexy, Pituitary
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D011333 Pro-Opiomelanocortin A 30-kDa protein synthesized primarily in the ANTERIOR PITUITARY GLAND and the HYPOTHALAMUS. It is also found in the skin and other peripheral tissues. Depending on species and tissues, POMC is cleaved by PROHORMONE CONVERTASES yielding various active peptides including ACTH; BETA-LIPOTROPIN; ENDORPHINS; MELANOCYTE-STIMULATING HORMONES; and others (GAMMA-LPH; CORTICOTROPIN-LIKE INTERMEDIATE LOBE PEPTIDE; N-terminal peptide of POMC or NPP). POMC,Pro-Opiocortin,ACTH-Endorphin Precursor,ACTH-beta-Lipotropin Precursor,Corticotropin-beta-Lipotropin Precursor,Endorphin-ACTH Precursor,Opiocortin,Pre-POMC,Pre-pro-opiocortin,Preproopiomelanocortin,Pro-ACTH-Endorphin,Pro-Opio-Melanocortin,Proopiocortin,Proopiomelanocortin,ACTH Endorphin Precursor,ACTH beta Lipotropin Precursor,Corticotropin beta Lipotropin Precursor,Endorphin ACTH Precursor,Pre POMC,Pre pro opiocortin,Pro ACTH Endorphin,Pro Opio Melanocortin,Pro Opiocortin,Pro Opiomelanocortin
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000236 Adenoma A benign epithelial tumor with a glandular organization. Adenoma, Basal Cell,Adenoma, Follicular,Adenoma, Microcystic,Adenoma, Monomorphic,Adenoma, Papillary,Adenoma, Trabecular,Adenomas,Adenomas, Basal Cell,Adenomas, Follicular,Adenomas, Microcystic,Adenomas, Monomorphic,Adenomas, Papillary,Adenomas, Trabecular,Basal Cell Adenoma,Basal Cell Adenomas,Follicular Adenoma,Follicular Adenomas,Microcystic Adenoma,Microcystic Adenomas,Monomorphic Adenoma,Monomorphic Adenomas,Papillary Adenoma,Papillary Adenomas,Trabecular Adenoma,Trabecular Adenomas

Related Publications

T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Prevalence of clinically silent corticotroph macroadenomas.
December 2016, Clinical endocrinology,
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
[Silent corticotroph adenomas: presentation of two cases that presented with pituitary apoplexy].
April 2004, Neurocirugia (Asturias, Spain),
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
A composite somatotroph-corticotroph pituitary adenoma.
December 1994, Endocrine pathology,
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Silent Corticotroph and Somatotroph Double Pituitary Adenoma: A Case Report and Review of Literature.
April 2022, Journal of neurological surgery reports,
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Sparsely Granulated Corticotroph Pituitary Macroadenoma Presenting With Pituitary Apoplexy Resulting in Remission of Hypercortisolism.
January 2022, AACE clinical case reports,
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Corticotroph carcinoma presenting as a silent corticotroph adenoma.
January 2003, Pituitary,
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Silent somatotroph pituitary adenomas: an update.
April 2018, Pituitary,
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Cushing's disease: a comparison of pituitary corticotroph microadenomas and macroadenomas.
February 1998, European journal of endocrinology,
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Pituitary apoplexy in nonfunctioning pituitary macroadenomas: a case-control study.
December 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
T Abe, and M Taniyama, and B Xu, and H Ozawa, and N Kawamura, and M Shimazu, and K Sasaki, and H Izumiyama, and M Kushima, and J Kuwazawa, and T Sano, and K Matsumoto
Pituitary apoplexy presenting with epistaxis.
March 1984, Journal of clinical neuro-ophthalmology,
Copied contents to your clipboard!